Comment on US trade representative support of the temporary waiver of intellectual property for COVID-19 vaccines Search Polity Note: Search is limited to the most recent 250 articles. To access earlier articles, click Advanced Search and set an earlier date range. To search for a term containing the '&' symbol, click Advanced Search and use the 'search headings' and/or 'in first paragraph' options. With... Clear Search Sponsored by Sponsored by The Fix the Patent Laws campaign welcomes the announcement that the Biden-Harris Administration supports the temporary waiver of intellectual property protections for COVID-19 vaccines. “This decision is as result of massive global solidarity and mobilisation by activists around the world, who have been fighting for equitable access for COVID-19 vaccines for all. While we commend this decision, it is important the waiver applies to all COVID-19 medical tools, including treatment and diagnostics, and not just vaccines,” says Umunyana Rugege, Executive Director of SECTION27.